Pew: Louisiana Could Use 340B To Avoid Medicaid Best Price Waivers

October 12, 2018
Pew Charitable Trusts says states could use a subscription-based model to buy hepatitis C drugs without triggering the Medicaid best price law by routing the medications through 340B hospitals. Brand-drug companies are trying to scale back the 340B drug discount program, but Pew Drug Spending Research Institute Officer Sean Dickson said Pew’s approach wouldn’t expand the 340B program. “This is not about 340B,” Dickson said. “It’s about providing a solution to best price concerns that doesn’t require waiving best price.”...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.